Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
According to researchers in Michigan, eating disorder hospitalisations among adolescents increased during the COVID pandemic - as "their entire worlds were turned upside down overnight".
An Australian team found that antibodies created by infection with the virus are not effective against COVID variants - suggesting that vaccination gives stronger protection.
The British Medical Association (BMA) today (7 July) responded to UK 'unlockdown' plans - labelling the suspension of all protective measures as "incoherent", with the NHS under "immense pressure".
Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.
The Lambda variant, originating in Peru, has been found in 32 countries - but for the moment, it remains classified as a less threatening Variant of Interest.
SAGE say the UK Governments' plans to lift all social distancing measures on 19 July are too much - they believe a rise in infections will increase ethnic minority COVID deaths.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
A study on New York City neighbourhoods found that "neighbourhood disadvantage", a mix of inequality measurements, is connected to a higher rate of COVID-19 cases.
The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.
The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
